ArticleBiochemia medica2026
Indirect estimation of serum enzymes reference intervals in adults using the reflimR and refineR algorithms.
Article in Biochemia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Many clinical laboratories rely on manufacturer-provided reference intervals (RIs) because of logistical and financial constraints of direct RI estimation. Indirect estimation methods offer a practical alternative for deriving RIs from laboratory data. This study aimed to estimate RIs for eight serum enzymes using the R-based algorithm reflimR, and to compare them with refineR, manufacturer's instructions for use (IFU), and direct methods. Materials and methods: Data from adult outpatients tested between January 2021 and May 2022 were retrospectively analyzed for alkaline phosphatase (ALP), alanine aminotransferase (ALT), amylase, aspartate aminotransferase (AST), creatine kinase (CK), gamma-glutamyl transferase (GGT), lactate dehydrogenase and lipase. Reference intervals were estimated using reflimR and refineR, and compared with IFU and direct RIs. Overlap between lower and upper limits was evaluated using a color-coded scheme. Data distribution was tested with Shapiro-Wilk; and Mann-Whitney U and Spearman's correlation tests were used for group comparisons and correlations. Results: Sex-specific RIs were required for ALP, ALT, AST, CK and GGT. ReflimR generally produced wider intervals than refineR. Agreement of reflimR with refineR, parametric, and IFU-based RIs was 88.5%, 72.7%, and 62.5%, respectively. The lowest agreement was observed with the non-parametric method (55.0%). Conclusions: ReflimR provides a practical approach for indirect RIs estimation from routine data. Its performance was comparable to refineR and parametric methods, supporting its use for verifying or updating local RIs, especially where population-specific RIs are unavailable. To our knowledge, this is the first study to apply reflimR to the Turkish population and directly compare its performance with refineR and IFUs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.